COM:PLIANTRX
Pliant Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
pliantrx.comlinkedin
pliant-therapeuticsipo date
Jun 03, 2020
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PL...Show More